Top compounds associated with response to HARS


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA apicidin CTRPv2 pan-cancer AAC -0.12 0.0001
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.12 0.0004
Download CSV